The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 43, Issue 12, 2004, Pages 2260-2264

  Moon, James C C ^a   Reed, Emma ^a   Sheppard, Mary N ^a   Elkington, Andrew G ^a   Ho, Siew Yen ^a   Burke, Margaret ^a   Petrou, Mario ^a   Pennell, Dudley J ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

cardiovascular magnetic resonance; CMR; HCM; hypertrophic cardiomyopathy; left ventricle ventricular; LV; right ventricular; RV

Indexed keywords

COLLAGEN; GADOLINIUM PENTETATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENDOCARDIUM; EPICARDIUM; HEART FAILURE; HEART MOVEMENT; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; COLLAGEN; CONTRAST MEDIA; GADOLINIUM DTPA; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIUM; RADIOGRAPHIC IMAGE ENHANCEMENT; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2942571691     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.035     Document Type: Article

References (19)

1. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 343:2000;1445-1453
2. Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 357:2001;21-28
3. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 40:2002;2156-2164
4. Moon J.C.C., McKenna W., McCrohon J.A., Elliott P.M., Smith G.C., Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 41:2003;1561-1567
5. Kim R.J., Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy In vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol. 4:2003;1568-1572
6. Maron B.J. Hypertrophic cardiomyopathy A systematic review. JAMA. 287:2002;1308-1320
7. Basso C., Thiene G., Corrado D., Buja G., Melacini P., Nava A. Hypertrophic cardiomyopathy and sudden death in the young Pathologic evidence of myocardial ischemia. Hum Pathol. 31:2000;988-998
8. Emoto R., Yokota Y., Miki T., et al. Prognosis of hypertrophic cardiomyopathy Echocardiographic and postmortem histopathologic study of 30 patients. J Cardiol. 18:1988;695-703
9. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 218:2001;215-223
10. Puchtler H., Waldrop F.S., Valentine L.S. Polarization microscopic studies of connective tissue stained with picro-sirius red. Beitr Pathol. 150:1973;174-187
11. Junqueira L.C., Bignolas G., Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 11:1979;447-455
12. Kim R.J., Chen E.L., Lima J.A.C., Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 94:1996;3318-3326
13. Flacke S.J., Fischer S.E., Lorenz C.H. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo Normal distribution and elevation in acute and chronic infarction. Radiology. 218:2001;703-710
14. Shirani J., Pick R., Roberts W.C., Maron B.J. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 35:2000;36-44
15. Kitamura M., Shimizu M., Ino H., et al. Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy The significance of type iii and vi collagens. Clin Cardiol. 24:2000;325-329
16. Anderson K.R., Sutton M.G., Lie J.T. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol. 128:1979;79-85
17. Kuribayashi T., Roberts W.C. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol. 70:1992;1333-1340
18. McCrohon J.A., Moon J.C.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance. Circulation. 108:2003;54-59
19. Moon J.C., Mundy H.R., Lee P.J., Mohiaddin R.H., Pennell D.J. Images in cardiovascular medicine Myocardial fibrosis in glycogen storage disease type iii. Circulation. 107:2003;E47